Filing Details
- Accession Number:
- 0001237899-12-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-15 16:52:25
- Reporting Period:
- 2012-02-13
- Filing Date:
- 2012-02-15
- Accepted Time:
- 2012-02-15 16:52:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226689 | Neil Stahl | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Research And Development S | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-13 | 63,234 | $8.50 | 122,355 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-13 | 4,741 | $113.35 | 117,614 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-02-13 | 28,869 | $113.35 | 88,745 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2012-02-13 | 3,432 | $8.50 | 92,177 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-13 | 257 | $113.35 | 91,920 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-02-13 | 1,597 | $113.35 | 90,323 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2012-02-14 | 50,000 | $16.80 | 140,323 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-14 | 7,566 | $111.01 | 132,757 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-02-14 | 21,352 | $111.01 | 111,405 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-02-14 | 333 | $107.83 | 111,072 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-14 | 2,350 | $108.60 | 108,722 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-14 | 8,510 | $109.61 | 100,212 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-14 | 17,694 | $110.35 | 82,518 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-14 | 600 | $111.91 | 81,918 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-14 | 1,115 | $112.10 | 80,803 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-14 | 600 | $113.47 | 80,203 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-15 | 19,057 | $107.79 | 61,146 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-15 | 2,025 | $108.09 | 59,121 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-13 | 63,234 | $0.00 | 63,234 | $8.50 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-13 | 3,432 | $0.00 | 3,432 | $8.50 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-14 | 50,000 | $0.00 | 50,000 | $16.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,432 | 2012-02-10 | 2012-12-20 | No | 4 | M | Direct |
0 | 2012-02-10 | 2012-12-20 | No | 4 | M | Direct |
69,048 | 2011-12-31 | 2018-12-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,335 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 333 shares of Company stock on February 14, 2012 at prices ranging from $107.62 to $107.96.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 2,350 shares of Company stock on February 14, 2012 at prices ranging from $108.03 to $108.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 8,510 shares of Company stock on February 14, 2012 at prices ranging from $109.02 to $109.98.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 17,694 shares of Company stock on February 14, 2012 at prices ranging from $110.00 to $110.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 600 shares of Company stock on February 14, 2012 at prices ranging from $111.79 to $111.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,115 shares of Company stock on February 14, 2012 at prices ranging from $112.00 to $112.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 600 shares of Company stock on February 14, 2012 at prices ranging from $113.25 to $113.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
- Represents volume-weighted average price of sales of 19,057 shares of Company stock on February 15, 2012 at prices ranging from $107.60 to $107.98 . Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2012 at each separate price.
- Represents volume-weighted average price of sales of 2,025 shares of Company stock on February 15, 2012 at prices ranging from $108.00 to $108.09 . Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2012 at each separate price.
- The option became exercisable with respect to all shares underlying the option upon the satisfaction by the company of certain performance criteria on February 10, 2012.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
- The option became exercisable with respect to all shares underlying the option on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011.